GlassScriptPhysician profile
Harold M Couch
NPI 1477753846
$2,780.53
in general payments reported to CMS, 2019-2025
22 companies · $429 in 2025
The $429 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $175 · 2021: $302 · 2022: $217 · 2023: $1,141 · 2024: $218 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,788.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $686.13 | 2022-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $639.38 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Karl Storz Endoscopy-America | $356.99 | 2023-2024 | Radiance, Image 1 |
| Smith+Nephew, INC. | $267.08 | 2019-2025 | Collagenase Santyl |
| Davol INC. | $247.98 | 2019-2023 | Phasix Mesh |
| Baxter Healthcare | $89.41 | 2024-2025 | Tisseel, Perclot |
| Integra Lifesciences Corporation | $82.65 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Acell, INC. | $82.36 | 2019-2020 | |
| Allergan, INC. | $45.31 | 2019-2021 | |
| Dilon Technologies, INC. | $40.43 | 2025 | Hemoblast Bellows |
| Organogenesis INC. | $34.43 | 2020 | |
| Innovation Technologies INC | $27.53 | 2020 | |
| Innocoll Pharmaceuticals Limited | $22.39 | 2021 | |
| Myriad Genetic Laboratories, INC. | $21.78 | 2021 | |
| Ethicon US, LLC | $21.28 | 2024 | Echelon Circular, Echelon; Endopath, Dermabond Prineo |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $19.71 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $18.19 | 2019 | |
| Molnlycke Health Care US, LLC | $17.67 | 2019 | |
| Bard Peripheral Vascular, INC. | $17.25 | 2020 | |
| Shire North American Group INC | $15.57 | 2019 | |
| Kerecis Limited | $15.45 | 2021 | |
| Novartis Pharmaceuticals Corporation | $11.56 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harold Couch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.